Your browser doesn't support javascript.
loading
Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A.
Hatchwell, Luke; Girkin, Jason; Dun, Matthew D; Morten, Matthew; Verrills, Nicole; Toop, Hamish D; Morris, Jonathan C; Johnston, Sebastian L; Foster, Paul S; Collison, Adam; Mattes, Joerg.
Afiliación
  • Hatchwell L; Experimental & Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Girkin J; Experimental & Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Dun MD; Medical Biochemistry Department, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hunter Medical Research Institute, Cancer Research Program and Hunter Cancer Research Alliance, Newcastle, Australia.
  • Morten M; Experimental & Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Verrills N; Medical Biochemistry Department, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hunter Medical Research Institute, Cancer Research Program and Hunter Cancer Research Alliance, Newcastle, Australia.
  • Toop HD; School of Chemistry, University of New South Wales, Sydney, Australia.
  • Morris JC; School of Chemistry, University of New South Wales, Sydney, Australia.
  • Johnston SL; Airway Disease Infection Section, National Heart and Lung Institute, Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
  • Foster PS; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Collison A; Experimental & Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Mattes J; Experimental & Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Paediat
J Allergy Clin Immunol ; 133(6): 1720-7, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24388637
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipersensibilidad Respiratoria / Rhinovirus / Quimiotaxis / Albuterol / Proteína Fosfatasa 2 / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Allergy Clin Immunol Año: 2014 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipersensibilidad Respiratoria / Rhinovirus / Quimiotaxis / Albuterol / Proteína Fosfatasa 2 / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Allergy Clin Immunol Año: 2014 Tipo del documento: Article País de afiliación: Australia